Last checked at 25 Jun 2019 08:44
25 June 2019
Venture Life Group plc
("Venture Life" or the "Group")
Director dealings
Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that Jerry Randall, Chief Executive Officer, today gifted for nil consideration, 20,400 ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares") to his grandchildren.
Furthermore, Mr Randall transferred 47,600 Ordinary Shares into his ISA and 47,600 Ordinary Shares into his wife, Anne Randall's ISA account. These transfers were facilitated by way of a sale and repurchase at a price of 41.2 pence per Ordinary Share. Additionally, Alfie Randall Mr Randall's son and therefore a person closely associated with him, transferred 10,200 Ordinary Shares into his Junior ISA account via a sale and repurchase at a price of 41.2 pence per Ordinary Share.
Following these transactions, Mr Randall is interested in 3,910,729 Ordinary Shares, representing approximately 4.7% of the issued share capital of the Company.
For further information, please contact:
Venture Life Group PLC | +44(0) 1344 578004 | ||
Jerry Randall, Chief Executive Officer
| |||
Cenkos Securities Ltd (Nomad and Broker) | +44(0)20 7397 8900 | ||
Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance) | |||
Russell Kerr / Michael Johnson (Sales) | |||
Alma PR | +44(0)20 3405 0208 | ||
Rebecca Sanders-Hewett / Hilary Buchanan / Helena Bogle / Jessica Joynson | |||
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Jerry Randall | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Chief Executive Officer | ||||||||
b) | Initial notification /Amendment | Initial Notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Venture Life Group plc | ||||||||
b) | LEI | 213800S8CZUPLAB2KC70 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.3p each in Venture Life Group plc | ||||||||
b) | Identification code | GB00BFPM8908 | ||||||||
c) | Nature of the transaction | Sale of shares and purchase of shares made through ISA | ||||||||
d)
| Price and volumes |
| ||||||||
d)
| Aggregated information - Aggregated volume - Price | See above
| ||||||||
e) | Date of the transaction | 24 June 2019 | ||||||||
f) | Place of the transaction | London Stock Exchange | ||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Jerry Randall & Anne Randall | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Jerry Randall, Chief Executive Officer Anne Randall a person closely associated with Jerry Randall | ||||||||
b) | Initial notification /Amendment | Initial Notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Venture Life Group plc | ||||||||
b) | LEI | 213800S8CZUPLAB2KC70 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.3p each in Venture Life Group plc | ||||||||
b) | Identification code | GB00BFPM8908 | ||||||||
c) | Nature of the transaction | Sale of shares from Mr Randall's general holding and purchase of shares through Anne Randall's ISA | ||||||||
d)
| Price and volumes |
| ||||||||
d)
| Aggregated information - Aggregated volume - Price | See above
| ||||||||
e) | Date of the transaction | 24 June 2019 | ||||||||
f) | Place of the transaction | London Stock Exchange | ||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
a) | Name | Alfie Randall | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | A person closely associated with Jerry Randall, Chief Executive Officer | ||||||||
b) | Initial notification /Amendment | Initial Notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | Venture Life Group plc | ||||||||
b) | LEI | 213800S8CZUPLAB2KC70 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.3p each in Venture Life Group plc | ||||||||
b) | Identification code | GB00BFPM8908 | ||||||||
c) | Nature of the transaction | Sale of shares and purchase of shares made through ISA | ||||||||
d)
| Price and volumes |
| ||||||||
d)
| Aggregated information - Aggregated volume - Price | See above
| ||||||||
e) | Date of the transaction | 24 June 2019 | ||||||||
f) | Place of the transaction | London Stock Exchange | ||||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Jerry Randall | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Venture Life Group plc | ||||
b) | LEI | 213800S8CZUPLAB2KC70 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.3p each in Venture Life Group plc | ||||
b) | Identification code | GB00BFPM8908 | ||||
c) | Nature of the transaction | Transfer of Ordinary Shares to his grandchildren for nil consideration | ||||
d) | Price and volumes |
| ||||
d)
| Aggregated information - Aggregated volume - Price |
N/A - single transaction | ||||
e) | Date of the transaction | 24 June 2019 | ||||
f) | Place of the transaction | London Stock Exchange | ||||